SYK INHIBITORS

The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I: wherein R 1 , R 2 , R 3 , and R 4 are as des...

Full description

Saved in:
Bibliographic Details
Main Authors SWAMINATHAN, SUNDARAMOORTHI, XIONG, JIN-MING, SCHMITT, AARON, C, ZHAO, ZHONGDONG, MITCHELL, SCOTT, A, BLOMGREN, PETER, A, KROPF, JEFFREY, E, LEE, SEUNG, H, CURRIE, KEVIN, S, XU, JIANJUN, LO, JENNIFER, R
Format Patent
LanguageEnglish
Serbian
Published 31.07.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I: wherein R 1 , R 2 , R 3 , and R 4 are as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts or co-crystals thereof, and methods of using these compounds and compositions to treat conditions mediated by Syk.
AbstractList The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I: wherein R 1 , R 2 , R 3 , and R 4 are as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts or co-crystals thereof, and methods of using these compounds and compositions to treat conditions mediated by Syk.
Author SCHMITT, AARON, C
KROPF, JEFFREY, E
CURRIE, KEVIN, S
ZHAO, ZHONGDONG
LO, JENNIFER, R
XIONG, JIN-MING
XU, JIANJUN
SWAMINATHAN, SUNDARAMOORTHI
LEE, SEUNG, H
BLOMGREN, PETER, A
MITCHELL, SCOTT, A
Author_xml – fullname: SWAMINATHAN, SUNDARAMOORTHI
– fullname: XIONG, JIN-MING
– fullname: SCHMITT, AARON, C
– fullname: ZHAO, ZHONGDONG
– fullname: MITCHELL, SCOTT, A
– fullname: BLOMGREN, PETER, A
– fullname: KROPF, JEFFREY, E
– fullname: LEE, SEUNG, H
– fullname: CURRIE, KEVIN, S
– fullname: XU, JIANJUN
– fullname: LO, JENNIFER, R
BookMark eNrjYmDJy89L5WTgC470VvD08_B08gzxDwrmYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxQcGm5oYWRk6GxgQVAADkeR25
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITORI SYK
ExternalDocumentID RS57182B1
GroupedDBID EVB
ID FETCH-epo_espacenet_RS57182B13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:35:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Serbian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_RS57182B13
Notes Application Number: RS2018P000332
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180731&DB=EPODOC&CC=RS&NR=57182B1
ParticipantIDs epo_espacenet_RS57182B1
PublicationCentury 2000
PublicationDate 20180731
PublicationDateYYYYMMDD 2018-07-31
PublicationDate_xml – month: 07
  year: 2018
  text: 20180731
  day: 31
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies GILEAD SCIENCES, INC
RelatedCompanies_xml – name: GILEAD SCIENCES, INC
Score 3.1532052
Snippet The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title SYK INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180731&DB=EPODOC&locale=&CC=RS&NR=57182B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUgzMrI0MTPRNUizBHZQjJINdC1SQVzz5ORUixSLlJQ00Iyur5-ZR6iJV4RpBBNDOmwvDPic0HLw4YjAHJUMzO8l4PK6ADGI5QJeW1msn5QJFMq3dwuxdVGD9o4NLYAp1lDNxcnWNcDfxd9ZzdnZNihYzS_I1hRYBhs5AbtJrMA2tDkoK7iGOYG2pBQg1yduggxsAUCj8kqEGJiKi4QZOJ1h164JM3D4Qme7gUxoxisWYeALjvRW8PTz8HTyDPEPChZlkHNzDXH20AUaHA_3QnxQMNQBxmIMLMB-faoEgwIwDs0tjJMSE1MMk0wsU00S04CdCSPQVlZT08TktGRJBnEchkjhlJFm4AKFAmTwUYaBpaSoNFUWWGuWJMmBfQwA-YhwLQ
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUgzMrI0MTPRNUizBHZQjJINdC1SQVzz5ORUixSLlJQ00Iyur5-ZR6iJV4RpBBNDOmwvDPic0HLw4YjAHJUMzO8l4PK6ADGI5QJeW1msn5QJFMq3dwuxdVGD9o4NLYAp1lDNxcnWNcDfxd9ZzdnZNihYzS_I1hRYBhs5AbtJrMD2tQXoqgPXMCfQlpQC5PrETZCBLQBoVF6JEANTcZEwA6cz7No1YQYOX-hsN5AJzXjFIgx8wZHeCp5-Hp5OniH-QcGiDHJuriHOHrpAg-PhXogPCoY6wFiMgQXYr0-VYFAAxqG5hXFSYmKKYZKJZapJYhqwM2EE2spqapqYnJYsySCOwxApnDLyDJweIb4-8T6eft7SDFygEIEMRMowsJQUlabKAmvQkiQ5sO8BYrhzHQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SYK+INHIBITORS&rft.inventor=SWAMINATHAN%2C+SUNDARAMOORTHI&rft.inventor=XIONG%2C+JIN-MING&rft.inventor=SCHMITT%2C+AARON%2C+C&rft.inventor=ZHAO%2C+ZHONGDONG&rft.inventor=MITCHELL%2C+SCOTT%2C+A&rft.inventor=BLOMGREN%2C+PETER%2C+A&rft.inventor=KROPF%2C+JEFFREY%2C+E&rft.inventor=LEE%2C+SEUNG%2C+H&rft.inventor=CURRIE%2C+KEVIN%2C+S&rft.inventor=XU%2C+JIANJUN&rft.inventor=LO%2C+JENNIFER%2C+R&rft.date=2018-07-31&rft.externalDBID=B1&rft.externalDocID=RS57182B1